| Literature DB >> 34351390 |
Darya Deen1, Falk Butter2, Deborah E Daniels3, Ivan Ferrer-Vicens3, Daniel C J Ferguson3, Michelle L Holland4, Vasiliki Samara5, Jacqueline A Sloane-Stanley5, Helena Ayyub5, Matthias Mann6, Jan Frayne3, David Garrick5, Douglas Vernimmen1.
Abstract
Erythropoiesis requires a combination of ubiquitous and tissue-specific transcription factors (TFs). Here, through DNA affinity purification followed by mass spectrometry, we have identified the widely expressed protein MAZ (Myc-associated zinc finger) as a TF that binds to the promoter of the erythroid-specific human α-globin gene. Genome-wide mapping in primary human erythroid cells revealed that MAZ also occupies active promoters as well as GATA1-bound enhancer elements of key erythroid genes. Consistent with an important role during erythropoiesis, knockdown of MAZ reduces α-globin expression in K562 cells and impairs differentiation in primary human erythroid cells. Genetic variants in the MAZ locus are associated with changes in clinically important human erythroid traits. Taken together, these findings reveal the zinc-finger TF MAZ to be a previously unrecognized regulator of the erythroid differentiation program.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34351390 PMCID: PMC8361462 DOI: 10.1182/bloodadvances.2021004609
Source DB: PubMed Journal: Blood Adv ISSN: 2473-9529